Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway.

scientific article published on 22 June 2016

Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1015516129
P356DOI10.1007/S13277-016-5123-X
P2888exact matchhttps://scigraph.springernature.com/pub.10.1007/s13277-016-5123-x
P698PubMed publication ID27329104

P50authorMohamed El-ShinawiQ59697022
Sherif A IbrahimQ59705197
Mona Mostafa MohamedQ62592797
P2093author name stringAmal Youns
Mohamed Akram Nouh
Tahani El-Mamlouk
Zeinab Hussein
Eslam A Elghonaimy
P2860cites workSignificance of axillary lymph node metastasis in primary breast cancerQ73181668
Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasionQ24321517
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingQ25938984
Molecular mechanisms of epithelial-mesenchymal transitionQ27013743
Epithelial-mesenchymal transitions in development and diseaseQ27860630
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modificationsQ28076697
Cancer stem cells in solid tumours: accumulating evidence and unresolved questionsQ28293535
Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early developmentQ30311953
Snail and Slug promote epithelial-mesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3Q30440581
RhoGDI2 promotes epithelial-mesenchymal transition via induction of Snail in gastric cancer cellsQ33688924
Why not treat human cancer with interleukin-1 blockade?Q33833871
Epithelial-mesenchymal transition: NF-kappaB takes center stageQ34367143
Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytesQ34411361
Cathepsin B: a potential prognostic marker for inflammatory breast cancerQ34499322
Interleukin-6 increases expression and secretion of cathepsin B by breast tumor-associated monocytesQ34537360
NF-κB-induced KIAA1199 promotes survival through EGFR signallingQ34563758
Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferationQ34978807
Molecular signatures of lymph node status by intrinsic subtype: gene expression analysis of primary breast tumors from patients with and without metastatic lymph nodesQ35066446
Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signalingQ35083176
Insights into the mechanisms of lymph node metastasisQ35181938
Interleukin-5 facilitates lung metastasis by modulating the immune microenvironmentQ35463907
Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancerQ35586223
NF-κB, stem cells and breast cancer: the links get strongerQ35608668
Expression of EMT Markers SLUG and TWIST in Breast Cancer.Q35678230
Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer CellsQ35710589
Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1Q35952706
Capturing and characterizing immune cells from breast tumor microenvironment: an innovative surgical approach.Q36109399
Metastasis: recent discoveries and novel treatment strategiesQ36407511
Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemopreventionQ36638387
Knockdown of PSCA induces EMT and decreases metastatic potentials of the human prostate cancer DU145 cellsQ36687126
Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expressionQ36945006
Immune cells as mediators of solid tumor metastasisQ37027344
IL4 and IL-17A provide a Th2/Th17-polarized inflammatory milieu in favor of TGF-β1 to induce bronchial epithelial-mesenchymal transition (EMT).Q37054538
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progressionQ37286365
Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.Q37346143
Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell linesQ37356654
Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic propertiesQ37592080
Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular linksQ38007261
Tectorigenin ablates the inflammation-induced epithelial-mesenchymal transition in a co-culture model of human lung carcinoma.Q38906344
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells.Q38911110
Radiation promotes invasiveness of non-small-cell lung cancer cells through granulocyte-colony-stimulating factorQ38914414
Activated macrophages down-regulate expression of E-cadherin in hepatocellular carcinoma cells via NF-κB/Slug pathwayQ38988561
Positive lymph-node breast cancer patients – activation of NF-κB in tumor-associated leukocytes stimulates cytokine secretion that promotes metastasis via C-C chemokine receptor CCR7.Q39110988
CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signalingQ39155541
The p65 subunit of NF-κB and PARP1 assist Snail1 in activating fibronectin transcriptionQ39416485
Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancerQ39893964
Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transitionQ40120833
FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancerQ41548013
Implications of the Notch1-Snail/Slug-epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma.Q53627868
Analysis of epidermal growth factor-induced NF-κB signaling.Q55066424
Nuclear Factor-kB Tumor Expression Predicts Response and Survival in Irinotecan-Refractory Metastatic Colorectal Cancer Treated With Cetuximab-Irinotecan TherapyQ57758325
P2507corrigendum / erratumErratum to: Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-kB/p65 signaling pathwayQ46588347
P433issue9
P921main subjectNF-κBQ411114
secretomeQ17042943
P304page(s)12441-12453
P577publication date2016-06-22
P1433published inTumor BiologyQ15757842
P1476titleSecretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway
P478volume37

Reverse relations

cites work (P2860)
Q33869755EMT and inflammation: inseparable actors of cancer progression.
Q47716837Gaining insights into cancer biology through exploration of the cancer secretome using proteomic and bioinformatic tools.
Q97645872HB-EGF Activates the EGFR/HIF-1α Pathway to Induce Proliferation of Arsenic-Transformed Cells and Tumor Growth
Q64119982MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2
Q38659528Proteomic profiling of the cancer cell secretome: informing clinical research.
Q37686006Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways
Q50308942Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway.

Q46588347Erratum to: Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-kB/p65 signaling pathwaymain subjectP921

Search more.